• OPEN AN ACCOUNT
Indian Indices
Sensex
81,106.65 107.25
( 0.13%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
58,738.13 1,303.36
(2.27%)
Nikkei 225
10,779.79 105.85
(0.99%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
64.6353737
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
30.57
3124.8
EPS(TTM)
Face Value()
Div & Yield %
9.33
2
1.92
 

mphasis ltd
GACM Technologies successfully concludes QIP issue of Rs 49.50 cr
Aug 22,2026

GACM Technologies announced the successful completion of its Qualified Institutions Placement (QIP). Through the QIP, the Company allotted 49.50 crore fully paid-up equity shares of face value Re 1 each at an issue price of Re 1 per equity share, aggregating to Rs 49.50 crore.

The QIP witnessed participation from overseas institutional investors, including funds based in Mauritius and registered under the applicable Foreign Portfolio Investor (FPI) framework. The participation of these institutional investors represents a significant development for GACM Technologies and further enhances the Company's visibility among global investment institutions.